| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |